← Browse by Condition
Medical Condition
lymphoma mantle cell
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT06558604 Phase 2
Recruiting
Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma
Enrollment
100 pts
Location
Belgium, France
Sponsor
The Lymphoma Academic Research...
NCT06136351 Phase 2
Recruiting
A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma
Enrollment
23 pts
Location
China
Sponsor
Ruijin Hospital